AMPH

28.43

0.25% -0.07

Handel nachbörslich: 28.43

Amphastar Pharmaceuticals Inc (AMPH)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt AMPH? Forum Prognose

Schlusskurs vom Vortag:

$28.50

Offen:

$28.45

24-Stunden-Volumen:

386.84K

Relative Volume:

0.67

Marktkapitalisierung:

$1.35B

Einnahmen:

$723.55M

Nettoeinkommen (Verlust:

$157.72M

KGV:

9.4767

EPS:

Netto-Cashflow:

$170.15M

1W Leistung:

+0.49%

1M Leistung:

-9.72%

6M Leistung:

-40.80%

1J Leistung:

-35.25%

1-Tages-Spanne:

$28.23

$28.71

1-Wochen-Bereich:

$27.80

$28.83

52-Wochen-Spanne:

$25.89

$53.95

Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile

Firmenname

Amphastar Pharmaceuticals Inc

Sektor

Healthcare (1166)

Branche

Drug Manufacturers - Specialty & Generic (1)

Telefon

909-980-9484

Adresse

11570 SIXTH STREET, RANCHO CUCAMONGA, CA

Mitarbeiter

2,028

Twitter

Nächster Verdiensttermin

2024-12-06

Neueste SEC-Einreichungen

AMPH's Discussions on Twitter

Vergleichen Sie AMPH mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
AMPH Amphastar Pharmaceuticals Inc	28.43	1.35B	723.55M	157.72M	170.15M	3.00
ZTS Zoetis Inc	163.11	73.07B	9.26B	2.49B	2.30B	5.47
TAK Takeda Pharmaceutical Co Adr	15.05	47.43B	30.25B	1.37B	5.08B	0.4257
HLN Haleon Plc Adr	10.24	45.72B	14.35B	1.85B	0	0.4023
TEVA Teva Pharmaceutical Industries Ltd Adr	15.08	17.28B	16.54B	-1.64B	749.00M	-1.45
ITCI Intra Cellular Therapies Inc	131.81	14.03B	612.78M	-86.37M	-62.91M	-0.87

Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-02-04	Herabstufung	Piper Sandler	Overweight → Neutral
2024-11-22	Eingeleitet	Wells Fargo	Equal Weight
2024-03-05	Eingeleitet	JP Morgan	Overweight
2023-11-17	Eingeleitet	BofA Securities	Neutral
2023-07-25	Fortgesetzt	Jefferies	Buy
2022-10-21	Fortgesetzt	Jefferies	Buy
2022-07-29	Eingeleitet	CapitalOne	Overweight
2022-01-07	Hochstufung	Piper Sandler	Neutral → Overweight
2021-01-08	Herabstufung	Wells Fargo	Overweight → Equal Weight
2020-10-05	Hochstufung	Northland Capital	Market Perform → Outperform
2020-05-01	Eingeleitet	Northland Capital	Outperform
2019-03-13	Herabstufung	Needham	Buy → Hold
2019-03-13	Herabstufung	Piper Jaffray	Overweight → Neutral
2018-08-10	Bestätigt	Needham	Buy
2018-03-13	Bestätigt	Needham	Buy
2017-12-01	Bestätigt	Needham	Buy
2017-11-09	Herabstufung	Raymond James	Outperform → Mkt Perform
2017-09-27	Bestätigt	Needham	Buy
2017-03-14	Herabstufung	Raymond James	Strong Buy → Outperform
2016-08-09	Bestätigt	Needham	Buy
2016-05-10	Bestätigt	Needham	Buy
2016-02-19	Eingeleitet	Wells Fargo	Outperform
2015-06-19	Bestätigt	Needham	Buy
2015-06-03	Eingeleitet	Raymond James	Strong Buy
2014-07-21	Eingeleitet	Needham	Buy

Alle ansehen

Amphastar Pharmaceuticals Inc Aktie (AMPH) Neueste Nachrichten

Mar 30, 2025

Raymond James Financial Inc. Takes $3.45 Million Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Mar 30, 2025

Mar 29, 2025

Quantbot Technologies LP Invests $945,000 in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Mar 29, 2025

(AMPH) Investment Report - Stock Traders Daily

Mar 29, 2025

Mar 28, 2025

Fox Run Management L.L.C. Takes $688,000 Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Mar 28, 2025

International Medication Systems, Ltd. Receives FDA's Drug Shortage Assistance Award - ACCESS Newswire

Mar 28, 2025

Amphastar Wins FDA Award: How Its Solution to Critical Drug Shortage Signals Major Growth - StockTitan

Mar 28, 2025

Mar 26, 2025

Intech Investment Management LLC Increases Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Mar 26, 2025

Mar 25, 2025

Piper Sandler Cuts Amphastar Pharmaceuticals (NASDAQ:AMPH) Price Target to $32.00 - MarketBeat

Mar 25, 2025

Mar 24, 2025

Boston Partners Purchases Shares of 426,636 Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Mar 24, 2025

Hypoglycemia Pipeline 2025: FDA Approvals, Therapies, - openPR

Mar 24, 2025

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Acquired by PNC Financial Services Group Inc. - Defense World

Mar 24, 2025

Mar 23, 2025

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Purchased by Amundi - MarketBeat

Mar 23, 2025

Connor Clark & Lunn Investment Management Ltd. Cuts Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Mar 23, 2025

Piper Sandler Lowers Amphastar Pharmaceuticals (NASDAQ:AMPH) Price Target to $32.00 - Defense World

Mar 23, 2025

Mar 22, 2025

Charles Schwab Investment Management Inc. Sells 2,544 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World

Mar 22, 2025

Amphastar stock target cut to $32 by Piper Sandler, maintains neutral - Investing.com Canada

Mar 22, 2025

Mar 21, 2025

Victory Capital Management Inc. Sells 155,144 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Mar 21, 2025

Mar 20, 2025

Amundi Acquires 12,899 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World

Mar 20, 2025

Mar 19, 2025